Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step 503B Compounding Master Guide Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read